Potency loss is cumulative and invisible a vial stored at 15C instead of 5C may lose 1020% potency over weeks without any visible change in appearance
The FDA shortage designation for semaglutide and tirzepatide - which originally provided the regulatory basis for much of the compounded GLP-1 market - has been resolved, and the FDA has proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list after stating it did not identify a clinical need for outsourcing facilities to compound those drugs from bulk substances
When youre running on empty, your body lets you know, through brain fog, fatigue, low immunity, or even a plateau in your wellness progress
Semaglutide, a medication designed to mimic the incretin hormones, stimulates insulin release in response to elevated blood glucose levels
the reversible properties of epigenetic modifications posit them as emerging potential targets for next-generation therapeutic interventions [1,2,3,4,5]
Hormone evaluation should precede GLP-1 dose calibration in midlife women
